Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Abstract
Muscarinic acetylcholine receptors (mAChRs), M(1)-M(5), regulate the activity of numerous fundamental central and peripheral functions. The lack of small-molecule ligands that can block or activate specific mAChR subtypes with high selectivity has remained a major obstacle in defining the roles of the individual receptor subtypes and in the development of novel muscarinic drugs. Recently, phenotypic analysis of mutant mouse strains deficient in each of the five mAChR subtypes has led to a wealth of new information regarding the physiological roles of the individual receptor subtypes. Importantly, these studies have identified specific mAChR-regulated pathways as potentially novel targets for the treatment of various important disorders including Alzheimer's disease, schizophrenia, pain, obesity and diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Gq/11-coupled M1, M3 and M5 mAChRs elicit Ca2+ release from the endoplasmic reticulum (ER) by activating the downstream phospholipase C/inositol 1,4,5-trisphosphate/inositol 1,4,5-trisphosphate receptor (PLC/IP3/IP3R) cascade49, the same pathway triggered by TCR signaling.”
From Tumor-specific cholinergic CD4+ T lymphocytes guide immunosurveillance of hepatocellular carcinoma (2023) · cites this paper as [49]
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
The role of acetylcholine in learning and memory
Hasselmo, M. E. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.09.002 · Cited by 1,693 · cited 1×
“Alzheimer's disease and cognitive impairments A convincing body of data indicate that mAChRs have central roles in facilitating cognitive function”
BackgroundInternational Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors
Caulfield, M. P., & Birdsall, N. J. M. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01362-0 · Cited by 1,474
Muscarinic Receptors—Characterization, coupling and function
Caulfield, M. P. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90027-b · Cited by 1,277
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072
Koob, G. F., Sanna, P. P., & Bloom, F. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80557-7 · Cited by 1,026
The current status of the dopamine hypothesis of schizophrenia
CARLSSON, A. (1988) · Neuropsychopharmacology · doi:10.1016/0893-133x(88)90012-7 · Cited by 958
Autonomic regulation of islet hormone secretion - Implications for health and disease
Ahrén, B. (2000) · Diabetologia · doi:10.1007/s001250051322 · Cited by 909
Cited by
Items 201–300 of 671
Thompson, K. J., & Tobin, A. B. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109545 · Cited by 42
Butcher, A. J., Bradley, S. J., Prihandoko, R., Brooke, S. M., Mogg, A. J., Bourgognon, J.-M., Macedo-Hatch, T., Edwards, J. M., Bottrill, A. R., Challiss, R. A. J., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.681726 · Cited by 43
The Muscarinic Acetylcholine Receptor M 5 : Therapeutic Implications and Allosteric Modulation
Bender, A. M., Garrison, A. T., & Lindsley, C. W. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00481 · Cited by 39
Allosteric Modulation of Muscarinic Acetylcholine Receptors
Jakubík, J., & El‐Fakahany, E. E. (2010) · Pharmaceuticals · doi:10.3390/ph3092838 · Cited by 50
Pathophysiology and pharmacology of G protein-coupled receptors in the heart
Grogan, A., Lucero, E. Y., Jiang, H., & Rockman, H. A. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac171 · Cited by 43
Fluoxetine induces vasodilatation of cerebral arterioles by co‐modulating NO /muscarinic signalling
Ofek, K., Schoknecht, K., Melamed‐Book, N., Heinemann, U., Friedman, A., & Soreq, H. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01596.x · Cited by 44
Park, J.-Y., & Spruston, N. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6519-11.2012 · Cited by 37
Regulation of M3 Muscarinic Receptor Expression and Function by Transmembrane Protein 147
Rosemond, E., Rossi, M., McMillin, S. M., Scarselli, M., Donaldson, J. G., & Wess, J. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.067363 · Cited by 40
Self-citationSabbir, M. G., & Fernyhough, P. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.020 · Cited by 46
Dean, B., Bakker, G., Ueda, H. R., Tobin, A. B., Brown, A., & Kanaan, R. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1124333 · Cited by 51
Watt, M. L., Schober, D. A., Hitchcock, S. A., Liu, B., Chesterfield, A. K., McKinzie, D. L., & Felder, C. C. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.182063 · Cited by 38
Bundel, D. D., Sarre, S., Eeckhaut, A. V., Smolders, I. J., & Michotte, Y. M. (2008) · Sensors · doi:10.3390/s8085171 · Cited by 38
Chan, J., & Sieburth, D. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2808-12.2012 · Cited by 40
Wang, L., Hagemann, T. L., Messing, A., & Feany, M. Β. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0256-15.2016 · Cited by 36
Ztaou, S., Lhost, J., Watabe, I., Torromino, G., & Amalric, M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14153 · Cited by 35
Overview of bile acid signaling in the cardiovascular system
Zhang, R., Ma, W., Fu, M., Li, J., Hu, C., Chen, Y., Zhou, M., Gao, Z., & He, Y. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i2.308 · Cited by 44
Sharma, M., Hunter, K. D., Fonseca, F. P., & Radhakrishnan, R. A. (2021) · Head & Neck · doi:10.1002/hed.26805 · Cited by 39
Muscarinic cholinergic receptor (M2) plays a crucial role in the development of myopia in mice
Barathi, V. A., Kwan, J. L., Tan, Q. S. W., Weon, S. R., Seet, L., Goh, L. K., Vithana, E. N., & Beuerman, R. W. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.010967 · Cited by 36
MacDonald, K., Kimber, M. J., Day, T. A., & Ribeiro, P. (2015) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2015.09.001 · Cited by 35
G-protein–coupled receptors are dynamic regulators of digestion and targets for digestive diseases
Canals, M., Poole, D. P., Veldhuis, N. A., Schmidt, B. L., & Bunnett, N. W. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.266 · Cited by 35
The retrotrapezoid nucleus and the neuromodulation of breathing
Moreira, T. S., Sobrinho, C. R., Falquetto, B., Oliveira, L. M., Lima, J. D., Mulkey, D. K., & Takakura, A. C. T. (2020) · Journal of Neurophysiology · doi:10.1152/jn.00497.2020 · Cited by 41
Pharmacological Approaches to Targeting Muscarinic Acetylcholine Receptors
Matera, C., & Tata, A. M. (2014) · Recent Patents on CNS Drug Discovery · doi:10.2174/1574889809666141120131238 · Cited by 47
Cheng, K., Xie, G., Khurana, S., Heath, J. E., Drachenberg, C. B., Timmons, J. A., Shah, N., & Raufman, J. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-77 · Cited by 41
Sabbir, M. G., Calcutt, N. A., & Fernyhough, P. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00402 · Cited by 39
Gentry, P. R., Kokubo, M., Bridges, T. M., Cho, H. P., Smith, E. W., Chase, P. S., Hodder, P., Utley, T. J., Rajapakse, A., Byers, F. W., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201402051 · Cited by 38
Zhu, L., Rossi, M., Cohen, A. H., Pham, J., Zheng, H., Dattaroy, D., Mukaibo, T., Melvin, J. E., Langel, J., Hattar, S. S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904943116 · Cited by 36
Self-citationThomsen, M., Fulton, B. S., & Caine, S. B. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3256-9 · Cited by 33
Current Management of the Cognitive Dysfunction in Parkinson’s Disease: How Far Have We Come?
Vale, S. (2008) · Experimental Biology and Medicine · doi:10.3181/0707-mr-193 · Cited by 38
Muscarinic Pain Pharmacology: Realizing the Promise of Novel Analgesics by Overcoming Old Challenges
Fiorino, D. F., & García‐Guzmán, M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-23274-9_9 · Cited by 36
Beyond Dopamine: Glutamate as a Target for Future Antipsychotics
Sendt, K.-V., Giaroli, G., & Tracy, D. K. (2012) · ISRN Pharmacology · doi:10.5402/2012/427267 · Cited by 40
Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators
Berizzi, A. E., Gentry, P. R., Rueda, P., den Hoedt, S., Sexton, P. M., Langmead, C. J., & Christopoulos, A. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.104182 · Cited by 41
Mei, L., Zhou, Y., Sun, Y., Liu, H., Zhang, D., Liu, P., & Shu, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.598811 · Cited by 34
Moehle, M. S., Bender, A. M., Dickerson, J. W., Foster, D. J., Qi, A., Cho, H. P., Donsante, Y., Peng, W., Bryant, Z., Stillwell, K. J., et al. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00162 · Cited by 36
Cholinergic Receptor Modulation as a Target for Preventing Dementia in Parkinson’s Disease
Iarkov, A., Mendoza, C., & Echeverría, V. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.665820 · Cited by 39
Poslusney, M. S., Melancon, B. J., Gentry, P. R., Sheffler, D. J., Bridges, T. M., Utley, T. J., Daniels, J. S., Niswender, C. M., Conn, P. J., Lindsley, C. W., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.01.017 · Cited by 32
Dean, B., Hopper, S., Conn, P. J., & Scarr, E. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.330 · Cited by 35
A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs
Owens, D. G. C. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139149112 · Cited by 46
MicroRNA Therapeutics in Neurological Disease
Greenberg, D., & Soreq, H. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140314151924 · Cited by 34
Discovery of ML326: The first sub-micromolar, selective M5 PAM
Gentry, P. R., Bridges, T. M., Lamsal, A., Vinson, P. N., Smith, E. W., Chase, P. S., Hodder, P., Engers, J. L., Niswender, C. M., Daniels, J. S., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.032 · Cited by 29
Acetylcholine in the cerebral cortex: Effects and clinical implications
Benarroch, E. E. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ee267e · Cited by 42
A new family of insect muscarinic acetylcholine receptors
Xia, R., Li, M. ‐., Wu, Y. ‐., Qi, Y., Ye, G. ‐., & Huang, J. (2016) · Insect Molecular Biology · doi:10.1111/imb.12229 · Cited by 32
Gorini, C., Philbin, K. E., Bateman, R., & Mendelowitz, D. (2010) · Journal of Neurophysiology · doi:10.1152/jn.00442.2010 · Cited by 39
Shi, Z., Chen, L., Li, S., Chen, S., Sun, X., Sun, L., Li, Y., Zeng, J., He, Y., & Liu, X. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3149-y · Cited by 32
Muscarinic ACh Receptors Contribute to Aversive Olfactory Learning inDrosophila
Silva, B., Molina-Fernández, C., Ugalde, M. B., Tognarelli, E. I., Angel, C., & Campusano, J. M. (2015) · Neural Plasticity · doi:10.1155/2015/658918 · Cited by 30
Klawonn, A. M., Wilhelms, D., Lindström, S., Singh, A. K., Jaarola, M., Wess, J., Fritz, M., & Engblom, D. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00139 · Cited by 30
Self-citationGentry, P. R., Kokubo, M., Bridges, T. M., Noetzel, M. J., Cho, H. P., Lamsal, A., Smith, E. W., Chase, P. S., Hodder, P., Niswender, C. M., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500995y · Cited by 28
Chan, J., Staab, T. A., Wang, H., Mazzasette, C., Butte, Z., & Sieburth, D. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1359-13.2013 · Cited by 33
Minireview: Novel Aspects of M3 Muscarinic Receptor Signaling in Pancreatic β-Cells
Nakajima, K., Jain, S., de Azúa, I. R., McMillin, S. M., Rossi, M., & Wess, J. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1084 · Cited by 34
Self-citationGenetics of GHRH, GHRH-receptor, GH and GH-receptor: Its impact on pharmacogenetics
Mullis, P. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.06.006 · Cited by 34
Novel Allosteric Effects of Amiodarone at the Muscarinic M5 Receptor
Stahl, E. L., & Ellis, J. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.165316 · Cited by 34
Drevets, W. C., Bhattacharya, A., & Furey, M. L. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.04.002 · Cited by 30
Matera, C., Flammini, L., Quadri, M., Vivo, V., Ballabeni, V., Holzgrabe, U., Mohr, K., Amici, M. D., Barocelli, E., Bertoni, S., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.01.032 · Cited by 28
Khan, W. U., Ghazala, Z., Brooks, H. J., Subramaniam, P., Mulsant, B. H., Kumar, S., Voineskos, A. N., Blumberger, D. M., Kern, R. S., & Rajji, T. K. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa093 · Cited by 27
Cristofaro, I., Spinello, Z., Matera, C., Fiore, M., Conti, L., Amici, M. D., Dallanoce, C., & Tata, A. M. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.04.010 · Cited by 37
Muscarinic Mechanisms in Psychotic Disorders
McKinzie, D. L., & Bymaster, F. P. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_9 · Cited by 28
Novel Insights into M3 Muscarinic Acetylcholine Receptor Physiology and Structure
Kruse, A. C., Li, J., Hu, J., Kobilka, B. K., & Wess, J. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0127-0 · Cited by 30
Self-citationZhang, W., Sun, Q. L., Gao, X., Jiang, Y., Li, R., & Ye, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066895 · Cited by 32
Dong, C., Beecham, A. H., Slifer, S., Wang, L., McClendon, M. S., Blanton, S. H., Rundek, T., & Sacco, R. L. (2010) · Human Genetics · doi:10.1007/s00439-010-0916-2 · Cited by 30
Muscarinic control of rostromedial tegmental nucleus GABA neurons and morphine‐induced locomotion
Wasserman, D., Tan, J. M. J., Kim, J. C., & Yeomans, J. S. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13237 · Cited by 31
Deletion of muscarinic acetylcholine receptor 3 in microglia impacts brain ischemic injury
Costa, A., Haage, V., Yang, S., Wegner, S., Ersoy, B., Ugursu, B., Rex, A., Kronenberg, G., Gertz, K., Endres, M., et al. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.09.008 · Cited by 23
Analgesic Effects Mediated by Muscarinic Receptors: Mechanisms and Pharmacological Approaches
Angelis, F. D., & Tata, A. M. (2016) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524916666160302103033 · Cited by 25
Characterization of PCS1055, a novel muscarinic M4 receptor antagonist
Croy, C. H., Chan, W., Castetter, A. M., Watt, M. L., Quets, A. T., & Felder, C. C. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.04.022 · Cited by 26
Current Findings and Potential Mechanisms of KarXT (Xanomeline–Trospium) in Schizophrenia Treatment
Azargoonjahromi, A. (2024) · Clinical Drug Investigation · doi:10.1007/s40261-024-01377-9 · Cited by 33
Qiu, W. Q. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.05.024 · Cited by 27
Crans, R. A. J., Wouters, E., Valle-León, M., Taura, J. J., Massari, C. M., Fernández‐Dueñas, V., Stove, C. P., & Ciruela, F. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00194 · Cited by 29
The unconventional activation of the muscarinic acetylcholine receptor M4R by diverse ligands
Wang, J., Wu, M., Chen, Z., Wu, L., Wang, T., Cao, D., Wang, H., Liu, S., Xu, Y., Li, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30595-y · Cited by 26
Nelson, A. R., Kolasa, K., & McMahon, L. L. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130608 · Cited by 26
Kohlmeier, K. A., Ishibashi, M., Wess, J., Bickford, M. E., & Leonard, C. S. (2012) · Journal of Neurophysiology · doi:10.1152/jn.01120.2011 · Cited by 28
Self-citationEnhanced self-administration of alcohol in muscarinic acetylcholine M4 receptor knockout mice
de la Cour, C. D., Sørensen, G., Wörtwein, G., Weikop, P., Dencker, D., Fink‐Jensen, A., & Molander, A. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.050 · Cited by 27
Human G protein-coupled receptor studies in Saccharomyces cerevisiae
Liu, R., Wong, W., & IJzerman, A. P. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.02.010 · Cited by 27
Valuskova, P., Farár, V., Forczek, S. T., Krizova, I., & Mysliveček, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00124 · Cited by 27
Zheng, F., Wess, J., & Alzheimer, C. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00740.2011 · Cited by 27
Self-citationAged Mice Devoid of the M3 Muscarinic Acetylcholine Receptor Develop Mild Dry Eye Disease
Musayeva, A., Jiang, S., Ruan, Y., Zadeh, J. K., Chronopoulos, P., Pfeiffer, N., Müller, W. E. G., Ackermann, M., Xia, N., Li, H., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116133 · Cited by 24
de Azúa, I. R., Nakajima, K., Rossi, M., Cui, Y., Jou, W., Gavrilova, O., & Wess, J. (2012) · The FASEB Journal · doi:10.1096/fj.12-204644 · Cited by 24
Self-citationZhang, L., Xiu, D., Zhan, J., He, X., Guo, L., Wang, J., Tao, M., Fu, W., & Zhang, H. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s111382 · Cited by 27
CAMKK2-CAMK4 signaling regulates transferrin trafficking, turnover, and iron homeostasis
Sabbir, M. G. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00575-0 · Cited by 28
Evers, A. S., Maze, M., & Kharasch, E. D. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781933.002 · Cited by 24
Litosch, I. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.03.037 · Cited by 33
Zhou, W., Chen, Z., Lü, A., & Liu, Z. (2021) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x2150018x · Cited by 24
Melancon, B. J., Poslusney, M. S., Gentry, P. R., Tarr, J. C., Sheffler, D. J., Mattmann, M. E., Bridges, T. M., Utley, T. J., Daniels, J. S., Niswender, C. M., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.11.092 · Cited by 23
Further optimization of the M5 NAM MLPCN probe ML375: Tactics and challenges
Kurata, H., Gentry, P. R., Kokubo, M., Cho, H. P., Bridges, T. M., Niswender, C. M., Byers, F. W., Wood, M. R., Daniels, J. S., Conn, P. J., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.11.082 · Cited by 23
Sariah, A., Liu, Z., Pu, W., Liu, H., Xue, Z., & Huang, X. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00016 · Cited by 23
Multidimensional Intersection of Nicotine, Gene Expression, and Behavior
Sherafat, Y., Bautista, M. R., & Fowler, C. D. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.649129 · Cited by 28
Takamura, Y., & Kakuta, H. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01714 · Cited by 23
Structural and Functional Diversity of Animal Toxins Interacting With GPCRs
van Baelen, A.-C., Robin, P., Kessler, P., Maïga, A., Gilles, N., & Servent, D. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.811365 · Cited by 29
Uwada, J., Anisuzzaman, A. S. M., Nishimune, A., Yoshiki, H., & Muramatsu, I. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07378.x · Cited by 24
Decker, M. W., & Holzgrabe, U. (2012) · MedChemComm · doi:10.1039/c2md20025b · Cited by 25
Markovic, D., Holdich, J., Al‐Sabah, S., Mistry, R., Krasel, C., Mahaut‐Smith, M. P., & Challiss, R. A. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029946 · Cited by 26
A Systems View of the Differences between APOE ε4 Carriers and Non-carriers in Alzheimer’s Disease
Jiang, S., Tang, L. Y., Zhao, N., Yang, W., Qiu, Y. L., & Chen, H. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00171 · Cited by 24
Soligo, M., Piccinin, S., Protto, V., Gelfo, F., Stefano, M. E. D., Florenzano, F., Berretta, E., Petrosini, L., Nisticò, R., & Manni, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-08556-z · Cited by 22
Choi, J. Y., Kim, J. E., Park, J. J., Lee, M. R., Song, B., Park, J. W., Kang, M. J., Lee, H. S., Son, H. J., Hong, J. T., et al. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100377 · Cited by 22
Novel Muscarinic Receptor Mutant Mouse Models
Wess, J. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-23274-9_6 · Cited by 24
Self-citationKubista, H., Kosenburger, K., Mahlknecht, P., Drobny, H., & Boehm, S. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00136.x · Cited by 22
Homology Modeling of Human Muscarinic Acetylcholine Receptors
Thomas, T., McLean, K. C., McRobb, F. M., Manallack, D. T., Chalmers, D. K., & Yuriev, E. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400502u · Cited by 21
Vahidinia, Z., Joghataei, M. T., Beyer, C., Karimian, M., & Tameh, A. A. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02435-5 · Cited by 24
Altered Brain Cholinergic and Synaptic Markers in Obese Zucker Rats
Martinelli, I., Tomassoni, D., Roy, P., Amenta, F., & Tayebati, S. K. (2021) · Cells · doi:10.3390/cells10102528 · Cited by 21
Shabani, S., Foster, R., Gubner, N. R., Phillips, T. J., & Mark, G. P. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.07.028 · Cited by 25
Martino, G., Puma, C., Xiao, Y., Gilbert, A.-K., Coupal, M., Markoglou, N., McIntosh, F., Perkins, M., & Laird, J. M. A. (2011) · Pain · doi:10.1016/j.pain.2011.09.017 · Cited by 21
Nabulsi, N., Holden, D., Zheng, M., Bois, F., Lin, S.-F., Najafzadeh, S., Gao, H., Ropchan, J. R., Lara‐Jaime, T., Labaree, D. C., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.222034 · Cited by 21
Teal, L. B., Gould, R. W., Felts, A. S., & Jones, C. K. (2019) · Advances in pharmacology · doi:10.1016/bs.apha.2019.05.001 · Cited by 26
Metadata
- Authors
- Wess, J., Eglen, R. M., & Gautam, D.
- Affiliations
- National Institutes of Health (US)
- PerkinElmer (United States) (US)
- Corresponding author
- Wess, Jürgen
- ORCID
- Wess, Jürgen
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-09
- Volume
- 6
- Issue
- 9
- Pages
- 721-733
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1999774383
- Cited by
- 637
- References
- 134
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 29 · 2023: 33 · 2022: 21 · 2021: 25 · 2020: 23 · 2019: 29 · 2018: 36 · 2017: 32 · 2016: 38 · 2015: 26 · 2014: 45 · 2013: 40 · 2012: 43
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- muscarinic receptors, knockout mice, Alzheimer's disease, schizophrenia, pain, obesity, diabetes mellitus, receptor function
- MeSH terms
- Animals, Disease Models, Animal, Ligands, Receptors, Muscarinic, Drug Design, Mice, Knockout, Muscarinic Agonists, Muscarinic Antagonists, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.